89bio, Inc. (ETNB) Net Income (Loss) Attributable to Parent USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
89bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • 89bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$51.7 M, a 79.2% decline year-over-year.
  • 89bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$165 M, a 56.7% decline year-over-year.
  • 89bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$142 M, a 39.4% decline from 2022.
  • 89bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$102 M, a 13.2% decline from 2021.
  • 89bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$90.1 M, a 82.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$165 M -$51.7 M -$22.8 M -79.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$142 M -$40.2 M -$15.6 M -63.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$127 M -$34.7 M -$7.92 M -29.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$119 M -$38.4 M -$13.3 M -53.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 -$105 M -$28.8 M -$3.27 M -12.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$102 M -$24.6 M +$1.69 M +6.41% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$104 M -$26.8 M +$1.52 M +5.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$105 M -$25.1 M -$4.33 M -20.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$101 M -$25.6 M -$10.8 M -72.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$90.1 M -$26.3 M -$13.7 M -109% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-01
Q3 2021 -$76.4 M -$28.3 M -$13.7 M -94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$62.7 M -$20.7 M -$8.95 M -76.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$53.7 M -$14.8 M -$4.24 M -40.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$49.5 M -$12.6 M +$6.7 M +34.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$56.2 M -$14.6 M +$4.12 M +22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$60.3 M -$11.8 M +$2.75 M +19% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$63.1 M -$10.5 M -$6.11 M -138% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$57 M -$19.3 M -$14.6 M -316% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-18
Q3 2019 -$42.3 M -$18.7 M -$14.6 M -350% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$27.8 M -$14.5 M -$7.15 M -97% Mar 31, 2019 Jun 30, 2019 10-Q 2019-12-18
Q1 2019 -$20.6 M -$4.44 M -$4.44 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$16.2 M -$4.64 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$4.17 M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-18
Q2 2018 -$7.37 M Mar 31, 2018 Jun 30, 2018 10-Q 2019-12-18
Q1 2018 $0 Jan 19, 2018 Mar 30, 2018 10-Q 2019-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.